The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of ...

The Institute for Clinical and Economic Review has identified five drugs — Biktarvy, Darzalex, Entresto, Cabometyx, and ...

Hepatocellular carcinoma (HCC) stands as the dominant form of liver cancer, ranking as the fourth leading cause of cancer-related deaths globally.

The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of ...

Hepatocellular carcinoma (HCC) is a significant global health issue, ranking as the sixth most prevalent malignancy and the ...

Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had ...

Hepatitis delta virus testing in those with chronic hepatitis B is low, and improvements are needed to reduce long-term, ...

A research result was announced that in the case of metabolic dysfunction-associated fatty liver disease (MAFLD), the risk of ...

Hepion Pharmaceuticals ( (HEPA) ) just unveiled an announcement.

Serious outcomes associated with metabolic dysfunction-associated steatotic liver disease (MASLD) -- including liver cancer, ...

—Sobia Laique, MD, of Cleveland Clinic, discusses the multitude of pathways that contribute to hepatocarcinogenesis in MASH, including metabolic derangement, gut microbiota, and more. (3:06 ...

This is frequently diagnosed in dogs that were never spayed and the only type of cancer in dogs that has research showing ...